Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ABGX

Abgenix (ABGX)

Abgenix (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ABGX

Date	Time	Source	Headline	Symbol	Company
03/30/2006	9:00AM	Business Wire	Amgen and Abgenix Complete Biologics License Application for FDA Approval of Panitumumab	NASDAQ:ABGX	Abgenix (MM)
03/29/2006	6:10PM	PR Newswire (US)	Abgenix Announces Stockholder Approval of Acquisition by Amgen	NASDAQ:ABGX	Abgenix (MM)
02/14/2006	8:30AM	PR Newswire (US)	Abgenix to Host Fourth Quarter and Full Year 2005 Conference Call	NASDAQ:ABGX	Abgenix (MM)
01/05/2006	8:30AM	PR Newswire (US)	Abgenix to Present at JPMorgan 24th Annual Healthcare Conference	NASDAQ:ABGX	Abgenix (MM)
12/14/2005	4:06PM	PR Newswire (US)	Amgen to Acquire Abgenix for $22.50 Per Share	NASDAQ:ABGX	Abgenix (MM)
11/09/2005	4:01PM	PR Newswire (US)	Abgenix Appoints Jeffrey H. Knapp as Senior Vice President of Sales and Marketing	NASDAQ:ABGX	Abgenix (MM)
11/03/2005	8:02AM	PR Newswire (US)	Panitumumab Significantly Improves Progression-Free Survival in Phase 3 Randomized Metastatic Colorectal Cancer Study	NASDAQ:ABGX	Abgenix (MM)
11/03/2005	8:01AM	Business Wire	Panitumumab Significantly Improves Progression-Free Survival in Phase 3 Randomized Metastatic Colorectal Cancer Study	NASDAQ:ABGX	Abgenix (MM)
11/03/2005	8:00AM	Business Wire	Media Notification/Webcast Notification - Amgen and Abgenix to Conduct Conference Call and Webcast Regarding Panitumumab Pivotal	NASDAQ:ABGX	Abgenix (MM)
11/03/2005	8:00AM	PR Newswire (US)	Media Notification/Webcast Notification - Amgen and Abgenix to Conduct Conference Call and Webcast Regarding Panitumumab Pivotal	NASDAQ:ABGX	Abgenix (MM)
10/25/2005	5:00PM	PR Newswire (US)	Abgenix Announces Third Quarter 2005 Financial Results	NASDAQ:ABGX	Abgenix (MM)
10/18/2005	5:30PM	PR Newswire (US)	Abgenix to Host Third Quarter 2005 Conference Call	NASDAQ:ABGX	Abgenix (MM)
09/01/2005	5:30PM	PR Newswire (US)	Abgenix to Webcast Three Upcoming Conference Presentations	NASDAQ:ABGX	Abgenix (MM)
08/01/2005	10:00AM	PR Newswire (US)	Abgenix and Amgen Announce FDA Grants Panitumumab Fast Track Designation for Metastatic Colorectal Cancer	NASDAQ:ABGX	Abgenix (MM)
07/26/2005	5:00PM	PR Newswire (US)	Abgenix Announces Second Quarter 2005 Financial Results	NASDAQ:ABGX	Abgenix (MM)
07/19/2005	5:30PM	PR Newswire (US)	Abgenix to Host Conference Call on Second Quarter 2005 Financial Results	NASDAQ:ABGX	Abgenix (MM)
06/28/2005	2:30PM	PR Newswire (US)	Abgenix to Consolidate Research Facilities in Preparation for Expanded Development and Commercial Operations	NASDAQ:ABGX	Abgenix (MM)
06/08/2005	5:30PM	PR Newswire (US)	Abgenix to Present at Goldman Sachs Twenty-Sixth Annual Global Healthcare Conference	NASDAQ:ABGX	Abgenix (MM)
05/20/2005	5:30PM	PR Newswire (US)	Abgenix to Present at Needham & Company's Fourth Annual Biotechnology Conference	NASDAQ:ABGX	Abgenix (MM)
05/17/2005	9:00AM	PR Newswire (US)	Further Phase 2 Data Confirm Panitumumab Single-Agent Antitumor Activity in Patients With Metastatic Colorectal Cancer	NASDAQ:ABGX	Abgenix (MM)
05/11/2005	8:30PM	PR Newswire (US)	Abgenix Appoints Marc Better, Ph.D., as Vice President of Process Sciences	NASDAQ:ABGX	Abgenix (MM)
04/26/2005	7:30PM	PR Newswire (US)	Phase 3 Clinical Trial Initiated to Evaluate the Use of Panitumumab Therapy For First-Line Treatment of Metastatic Colorectal Ca	NASDAQ:ABGX	Abgenix (MM)
04/26/2005	5:00PM	PR Newswire (US)	Abgenix Announces First Quarter 2005 Financial Results	NASDAQ:ABGX	Abgenix (MM)
04/18/2005	7:30AM	PR Newswire (US)	Abgenix to Host Conference Call on First Quarter 2005 Financial Results	NASDAQ:ABGX	Abgenix (MM)
04/15/2005	7:30AM	PR Newswire (US)	Abgenix Announces Data Presentations for Panitumumab at AACR and ASCO Annual Meetings	NASDAQ:ABGX	Abgenix (MM)
03/23/2005	4:00PM	PR Newswire (US)	Abgenix to Present at the Smith Barney Citigroup 2005 Healthcare Conference	NASDAQ:ABGX	Abgenix (MM)
03/18/2005	6:00AM	PR Newswire (US)	Panitumumab Pivotal Trial Completes Patient Enrollment	NASDAQ:ABGX	Abgenix (MM)
03/17/2005	4:53PM	PR Newswire (US)	Abgenix Files Resale Registration Statement	NASDAQ:ABGX	Abgenix (MM)
03/14/2005	9:01AM	PR Newswire (US)	Abgenix and Genentech Extend Antibody Technology Licensing Agreement	NASDAQ:ABGX	Abgenix (MM)
03/04/2005	4:00PM	PR Newswire (US)	Abgenix Appoints Donald R. Joseph as Senior Vice President, General Counsel and Secretary	NASDAQ:ABGX	Abgenix (MM)

Showing the most relevant articles for your search:NASDAQ:ABGX

Voip Pal Com (QB)

Kraig Biocraft Laborator... (QB)

Northwest Biotherapeutics (QB)

TheGlobe com (PK)

Digital Brand Media and ... (PK)

Lightwave Logic

Trump Media and Technology

Code Green Apparel (PK)

Asia Broadband (PK)

Delayed Upgrade Clock